- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: atypical chronic myeloid leukemia, BCR-ABL1 negative
Total 40897 results
-
Thomas Ernst, PD Dr. med.AbbVie; Ludwig-Maximilians - University of MunichRecruitingChronic Myeloid LeukemiaGermany
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireRecruiting
-
Grupo Cooperativo de Hemopatías MalignasRecruitingChronic Myeloid Leukaemia Recurrent | Chronic Myeloid Leukemia, in RelapseMexico
-
University of PisaRecruitingChronic Myeloid LeukemiaItaly
-
Novartis PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsTerminatedLeukemiaUnited States
-
European Society for Blood and Marrow TransplantationNovartisCompletedMyeloid Leukemia, ChronicGermany, Finland, Denmark, Poland, Saudi Arabia, United Kingdom, Israel, Hungary, Russian Federation
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaGermany
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
University Hospital, BordeauxRecruitingChronic Myeloid LeukemiaFrance
-
Novartis PharmaceuticalsActive, not recruitingChronic Myeloid LeukemiaJapan, Germany, Canada, Australia, France, Israel, Spain, United States, Greece, United Kingdom, Korea, Republic of, Russian Federation, Argentina, Brazil, Poland, Singapore, Belgium, Mexico
-
Novartis PharmaceuticalsCompleted
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg UniversityActive, not recruitingChronic Myeloid LeukemiaGermany, Netherlands
-
Assiut UniversityCompleted
-
PfizerCompleted
-
PfizerpH AssociatesCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
Polish Adult Leukemia GroupCompletedChronic Myeloid Leukemia
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
Jonsson Comprehensive Cancer CenterWithdrawnLeukemia | Graft Versus Host Disease
-
National Cancer Institute (NCI)CompletedLymphoma | Healthy | Chronic Myeloid Leukemia | Hematologic NeoplasmUnited States
-
Radboud University Medical CenterCompletedNeoplasms | Telemedicine | Chronic Myeloid Leukemia | Patient PortalsNetherlands
-
Novartis PharmaceuticalsCompletedChronic Myeloid Leukemia (CML)Korea, Republic of
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia - Accelerated PhaseChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Assiut UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
Novartis PharmaceuticalsActive, not recruiting
-
Novartis PharmaceuticalsCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUnited States, Germany, United Kingdom, Italy, France, Switzerland
-
University Hospital, AngersCompletedSolid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)France
-
Bristol-Myers SquibbCompletedLeukemia, Myeloid, Chronic-Phase (CML-CP)
-
Nanfang Hospital of Southern Medical UniversityRecruitingValidity and SafetyChina
-
Novartis PharmaceuticalsCompleted
-
Northwestern UniversityNational Cancer Institute (NCI); Augusta University; Fondazione GIMEMA - Franco...Completed
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaColombia, Venezuela
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia, Chronic Phase | Olverembatinib | Tyrosine Kinase InhibitorsChina
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaUnited States, Canada, France, Germany, Italy, Spain
-
Prism Pharma Co., Ltd.inVentiv Health ClinicalCompletedAcute Myeloid Leukemia | Chronic Myeloid LeukemiaUnited States
-
PETHEMA FoundationCompleted
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
European Society for Blood and Marrow TransplantationHoffmann-La Roche; AmgenCompletedAcute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous LeukemiaGermany
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingLeukemia, Chronic MyeloidItaly
-
Poitiers University HospitalRecruitingChronic Myeloid Leukemia | Tyrosine Kinase InhibitorsFrance
-
PETHEMA FoundationTerminatedPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALLSpain